FSAGX | IIGCX | FSAGX / IIGCX | |
Total Expense Ratio | 0.70 | 2.20 | 32% |
Annual Report Gross Expense Ratio | 0.70 | 2.25 | 31% |
Fund Existence | 39 years | 22 years | - |
Gain YTD | 22.905 | 22.422 | 102% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.93B | 777M | 249% |
Annual Yield % from dividends | 2.71 | 6.30 | 43% |
Returns for 1 year | 29.50 | 27.42 | 108% |
Returns for 3 years | 3.01 | 12.60 | 24% |
Returns for 5 years | 40.40 | 59.47 | 68% |
Returns for 10 years | 97.77 | 126.62 | 77% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FDTX | 31.19 | 3.33 | +11.95% |
Fidelity Disruptive Technology ETF | |||
BIB | 40.66 | 3.67 | +9.92% |
ProShares Ultra Nasdaq Biotechnology | |||
EFIV | 51.74 | 3.67 | +7.63% |
SPDR® S&P 500® ESG ETF | |||
QCLR | 27.44 | 1.15 | +4.38% |
Global X NASDAQ 100® Collar 95-110 ETF | |||
CAOS | 88.74 | -2.75 | -3.01% |
Alpha Architect Tail Risk ETF |